Glycemic Control for Diabetes Mellitus: Clinical Trials

9 trials for Glycemic Control for Diabetes Mellitus, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 not yet recruiting, 3 completed, 1 enrolling by invitation, 1 recruiting. 4 Not applicable, 2 Phase 2, 2 Phase 3.

By phase and status

PhaseTrialsStatus
Not applicable4Not yet recruiting 3, Completed 1
Phase 22Completed 1, Recruiting 1
Phase 32Enrolling by invitation 1, Not yet recruiting 1

Follow Glycemic Control for Diabetes Mellitus: new trials by email Literature Review of Glycemic Control for Diabetes Mellitus trials Research Report on Glycemic Control for Diabetes Mellitus

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study Evaluating the Metabolic Effects of pulsENDO Therapy in Adults With Type 2 Diabetes
pulsENDO Therapy - Diabetes Type 2, Diabetes
Not applicableNot yet recruitingEndogenex, Inc.3202027-01-012026-08-18
Video-Based Lifestyle Counseling in Adults With Type 2 Diabetes.
Video-based lifestyle intervention (own physician), Video-based lifestyle intervention (unknown physician) - Diabetes Mellitus (Type 2), Glycemic Control for Diabetes Mellitus
Not applicableNot yet recruitingCardenal Herrera University1562026-09-012026-04-29
Evaluation of a Novel Insulin Sensitizer in People With Type 1 Diabetes
CIR-0602K, Placebo - Type 1 Diabetes (T1D), Glycemic Control for Diabetes Mellitus
Phase 2RecruitingUniversity of Virginia402026-02-222026-02-25
Semaglutide Treatment in Type 1 Diabetes
Semaglutide 2.4mg, Semaglutide placebo - Obesity in Diabetes, Obesity/Therapy
Phase 3Not yet recruitingNordsjaellands Hospital1222025-10-012025-08-08
Comparison Between Efficacy of Trelagliptin and Sitagliptin in Type II Diabetic Patients
Trelagliptin 100 mg, Sitagliptin 100mg OD - Diabetes Mellitus Type 2, Glycemic Control for Diabetes Mellitus
Phase 3Enrolling by invitationKhyber Medical College, Peshawar1262025-07-012025-07-18
Meal Frequency and Glycemic Control in Individuals With Type 1 Diabetes
Three meals a day, Six meals a day - Type 1 Diabetes (T1D), Nutrition Therapy
Not applicableNot yet recruitingHospital de Clinicas de Porto Alegre272025-04-202025-04-18
Real-life Follow-up of the Physical Activity in Type 1 Diabetes Participants Equipped With an Insulin Pump With Hybrid Closed Loop
No Intervention: Observational Cohort - Diabetes Mellitus Type 1, Glucose Metabolism Disorder
CompletedISIS Diabete Service872024-03-052026-01-26
Intermittent vs Continuous Enteral Nutrition in Glycaemic Control of Diabetic ICU Patients
Intermittent Enteral Nutrition, Continuous Enteral Nutrition (CE) - Diabetes Mellitus, Glycemic Control for Diabetes Mellitus
Not applicableCompletedHacettepe University252023-12-022025-07-08
The Empowerment Model Towards Type 2 Diabetic Adults To Enhance Vegetable Intake in Achieving Glycemic Control
Empowerment model to improve dietary intake, Control group following conventional approach - Glycemic Control for Diabetes Mellitus
Phase 2CompletedSEAMEO Regional Centre for Food and Nutrition842013-01-012015-07-01

Narrower conditions

Diabetes Mellitus, Type 1 (4)  ·  Diabetes Mellitus (3)  ·  Diabetes Mellitus, Type 2 (3)  ·  Insulin Resistance (2)  ·  Body Weight Changes (1)  ·  Glucose Metabolism Disorders (1)  ·  Hypoglycemia (1)  ·  Ketosis (1)  ·  Motor Activity (1)  ·  Obesity (1)  ·  Weight Loss (1)

Broader conditions

Endocrine System Diseases (8)  ·  Metabolic Diseases (8)  ·  Nutritional and Metabolic Diseases (8)  ·  Glucose Metabolism Disorders (7)  ·  Diabetes Mellitus (5)  ·  Autoimmune Diseases (4)  ·  Immune System Diseases (4)  ·  Body Weight (2)  ·  Hyperinsulinism (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Signs and Symptoms (2)  ·  Acid-Base Imbalance (1)  ·  Acidosis (1)  ·  Behavior (1)  ·  Body Weight Changes (1)

Interventions

Sitagliptin Phosphate (1)  ·  semaglutide (1)  ·  trelagliptin (1)

Sponsors

Cardenal Herrera University (1)  ·  Endogenex, Inc. (1)  ·  Hacettepe University (1)  ·  Hospital de Clinicas de Porto Alegre (1)  ·  ISIS Diabete Service (1)  ·  Khyber Medical College, Peshawar (1)  ·  Nordsjaellands Hospital (1)  ·  SEAMEO Regional Centre for Food and Nutrition (1)  ·  University of Virginia (1)

Countries

Brazil (1)  ·  Denmark (1)  ·  France (1)  ·  Indonesia (1)  ·  Pakistan (1)  ·  Spain (1)  ·  Turkey (Türkiye) (1)  ·  United States (1)

Top investigators

Aliena Badshah, MBBS, FCPS, MRCP (1)  ·  Daniel DeMarco, M.D. (1)  ·  Fernando Gerchman (1)  ·  Tan S Yen, MSc (1)  ·  Thomas F Dejgaard, MD, ph.d., endocrinologist (1)  ·  William B. Horton, MD (1)

Results publications

PMID 34397596, PMID 40926369